"Immune Monitoring : T cell mucin 1-specific responses
Analysis of three patients after the first three doses of CVac has shown a mucin 1-specific T cell response while no response was observed in normal healthy volunteers nor untreated patients ."
An early lead on the ICS result for the full 7 cohort trial, which could be out any time.
This seems to be just what we're hoping for, potential to move into other treatment markets.
ann out , page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.5¢ | 30.5¢ | $328.6K | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 39589 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 284658 | 32 |
View Market Depth
| Last trade - 14.32pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |